tiprankstipranks
Trending News
More News >
Propanc Biopharma (PPCB)
NASDAQ:PPCB
US Market

Propanc Biopharma (PPCB) Financial Statements

Compare
63 Followers

Propanc Biopharma Financial Overview

Propanc Biopharma's market cap is currently $3.33M. The company's EPS TTM is $; its P/E ratio is -0.01; Propanc Biopharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 25Jun 24Jun 23Jun 22Jun 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -21.66K$ -17.76K$ -5.67K$ 0.00
Operating Income$ -57.28M$ -1.54M$ -1.78M$ -1.99M$ -1.81M
EBITDA$ -58.34M$ -1.26M$ -2.23M$ -2.14M$ -1.69M
Net Income$ -58.92M$ -1.82M$ -2.66M$ -2.66M$ -2.03M
Balance Sheet
Cash & Short-Term Investments$ 12.09K$ 21.09K$ 10.05K$ 4.07K$ 2.25K
Total Assets$ 19.63M$ 72.36K$ 60.33K$ 81.65K$ 13.10K
Total Debt$ 1.73M$ 948.27K$ 545.92K$ 1.04M$ 680.08K
Net Debt$ 1.71M$ 927.19K$ 535.87K$ 1.04M$ 677.83K
Total Liabilities$ 5.73M$ 3.85M$ 3.18M$ 3.11M$ 3.08M
Stockholders' Equity$ 13.91M$ -3.78M$ -3.12M$ -3.02M$ -3.07M
Cash Flow
Free Cash Flow$ -405.17K$ -935.12K$ -1.11M$ -1.44M$ -1.15M
Operating Cash Flow$ -405.17K$ -935.12K$ -1.11M$ -1.44M$ -1.15M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 490.76K$ 941.89K$ 1.11M$ 1.49M$ 1.06M
Currency in USD

Propanc Biopharma Earnings and Revenue History

Propanc Biopharma Debt to Assets

Propanc Biopharma Cash Flow

Propanc Biopharma Forecast EPS vs Actual EPS